Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Anti-D titration |
Has measured component (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
D blood group antibody identification |
Has measured component (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Rhogam screen |
Has measured component (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D titration |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
D blood group antibody identification |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Rhogam screen |
Component |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin adverse reaction |
Causative agent (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Allergy to blood group antibody D |
Causative agent (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunoglobulin 1250iu/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 250iu injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 500iu injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 2500iu injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 5000iu injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 600iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 1500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
immunoglobuline anti-Rh>o<(D) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D (Rh) immunoglobulin 5000iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
injection d'immunoglobuline anti-D (Rh) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 1500iu prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 1500iu prefilled 2mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D globulin NOS |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenous infusion of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuscular injection of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Injektion von RhD-Immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Administration of RhD immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D globulin NOS |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuscular injection of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Injektion von RhD-Immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenous infusion of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Administration of RhD immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Administration of RhD immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D globulin NOS |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuscular injection of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenous infusion of Rh immune globulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Allergy to blood group antibody D |
Causative agent (attribute) |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D (Rh) immunoglobulin 1500iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 5000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 600iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Product containing blood group antibody D in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Human anti-D immunoglobulin |
Is a |
True |
Blood group antibody D |
Inferred relationship |
Some |
|
Product containing only blood group antibody D (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing only blood group antibody D in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Rho(D) immune globulin screening (procedure) |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D isoimmunisation affecting pregnancy |
Causative agent (attribute) |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |